Non Vascular Stent Market
Description
The global non vascular stent market size was valued at $1.6 billion in 2023, and is estimated to reach $2.7 billion by 2035, growing at a CAGR of 4.5% from 2024 to 2035. Stents are tubular medical devices designed to keep passageways in the body open, typically used to treat obstructions or narrowing. They can be vascular, placed in blood vessels, or non vascular, used in lumens like the gastrointestinal, biliary, urinary, or respiratory tracts. Non vascular stents work by providing structural support to maintain patency in blocked or narrowed passages. They are deployed using minimally invasive techniques such as endoscopy or fluoroscopy and expand to the desired size, either through self-expansion or balloon dilation. Made from materials such as nitinol (a shape-memory alloy), stainless steel, polymers, or biodegradable substances, non vascular stents often feature coatings to reduce inflammation or prevent infection. These stents alleviate symptoms, improve organ function, and enhance quality of life.
Rise in aging population is one of the most significant drivers for the expansion of the non vascular stent market. According to the Population Reference Bureau (PRB), the number of Americans aged 65 and older is expected to increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. As the elderly population grows, the prevalence of age-related chronic diseases, such as gastrointestinal disorders, respiratory diseases, and cancers, also increases. These conditions often lead to obstructions in non vascular lumens, requiring stent placement to restore proper function and alleviate symptoms. Thus, demand for non vascular stents is expected to rise significantly as more elderly patients require these medical devices for effective treatment and symptom management.
In addition, rise in preference for minimally invasive procedures has played a critical role in driving market growth. Minimally invasive surgeries, such as stent placement, offer numerous benefits over traditional open surgeries, including shorter recovery times, reduced risk of complications, and improved patient comfort. These advantages make minimally invasive treatments highly attractive to both patients and healthcare providers, further accelerating the adoption of non vascular stents. The trend towards minimally invasive procedures is also fueled by rise in awareness of their benefits, encouraging patients to opt for less invasive alternatives for conditions such as biliary and gastrointestinal obstructions.
Moreover, technological innovation is contributing to the market growth by introducing advanced stent options that cater to a broader range of patient needs. Development of MRI-compatible stents has enhanced treatment options for patients who require magnetic resonance imaging (MRI) during their diagnosis or treatment. These MRI-compatible stents can withstand the magnetic field of MRI machines without compromising their functionality, making them suitable for a more extensive set of patients. As these technological advancements continue to improve, they will further contribute to the adoption and expansion of non vascular stents, addressing the evolving demands of the healthcare market and increasing patient outcomes. Thus, rise in aging population, rise in preference for minimally invasive options, and technological innovations drive the growth of the market.
The non vascular stent market is segmented into product type, material type, end user, and region. On the basis of product type, it is segmented into gastrointestinal stents, pulmonary (airway) stents, urological stents, and others. On the basis of material type, the market is classified into metallic stents, and non-metallic stents. On the basis of end user, it is classified into hospitals, ambulatory surgical centers, and others. On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include ELLA– CS, s.r.o., Boston Scientific Corporation, Hobbs Medical Inc., Becton, Dickinson & Company, W.L. Gore & Associate Inc., Medtronic Plc, MICRO-TECH (Nanjing) Co., Ltd., Q3 Medical Group, CONMED Corporation, and Cook Medical. The key players have adopted product approval as the key strategies for expansion of their product portfolio.
Key Benefits for Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non vascular stent market analysis from 2023 to 2035 to identify the prevailing non vascular stent market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the non vascular stent market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global non vascular stent market trends, key players, market segments, application areas, and market growth strategies.
Volume Market Size and Forecast
Key Market Segments
By Material Type
Metallic Stents
Non metallic Stents
By End User
Hospitals
Ambulatory Surgical Centers
Others
By Product Type
Gastrointestinal Stents
Pulmonary Stents
Urological Stents
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
ELLA – CS, s.r.o.
Becton, Dickinson, and Company
W.L. Gore & Associate Inc.
CONMED Corporation
Q3 Medical Group
Micro-tech (nanjing) Co., Ltd.
Hobbs Medical Inc.
Cook Group
Boston Scientific Corporation
Medtronic plcThe research methodology of the global market involves extensive primary and secondary research. Primary research includes about over 12 hours of interviews and discussion with a wide range of stakeholders, including upstream and downstream participants. The primary research typically is the bulk of our research efforts; however, coherently supported by extensive secondary research. Researchers have reviewed over 6,765 product literatures, industry releases, annual reports, and other such documents of key industry participants to obtain better market understanding and gain competitive intelligence. In addition, authentic industry journals, trade associations' releases,and government websites have also been reviewed for generating high-value industry insights.
Rise in aging population is one of the most significant drivers for the expansion of the non vascular stent market. According to the Population Reference Bureau (PRB), the number of Americans aged 65 and older is expected to increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. As the elderly population grows, the prevalence of age-related chronic diseases, such as gastrointestinal disorders, respiratory diseases, and cancers, also increases. These conditions often lead to obstructions in non vascular lumens, requiring stent placement to restore proper function and alleviate symptoms. Thus, demand for non vascular stents is expected to rise significantly as more elderly patients require these medical devices for effective treatment and symptom management.
In addition, rise in preference for minimally invasive procedures has played a critical role in driving market growth. Minimally invasive surgeries, such as stent placement, offer numerous benefits over traditional open surgeries, including shorter recovery times, reduced risk of complications, and improved patient comfort. These advantages make minimally invasive treatments highly attractive to both patients and healthcare providers, further accelerating the adoption of non vascular stents. The trend towards minimally invasive procedures is also fueled by rise in awareness of their benefits, encouraging patients to opt for less invasive alternatives for conditions such as biliary and gastrointestinal obstructions.
Moreover, technological innovation is contributing to the market growth by introducing advanced stent options that cater to a broader range of patient needs. Development of MRI-compatible stents has enhanced treatment options for patients who require magnetic resonance imaging (MRI) during their diagnosis or treatment. These MRI-compatible stents can withstand the magnetic field of MRI machines without compromising their functionality, making them suitable for a more extensive set of patients. As these technological advancements continue to improve, they will further contribute to the adoption and expansion of non vascular stents, addressing the evolving demands of the healthcare market and increasing patient outcomes. Thus, rise in aging population, rise in preference for minimally invasive options, and technological innovations drive the growth of the market.
The non vascular stent market is segmented into product type, material type, end user, and region. On the basis of product type, it is segmented into gastrointestinal stents, pulmonary (airway) stents, urological stents, and others. On the basis of material type, the market is classified into metallic stents, and non-metallic stents. On the basis of end user, it is classified into hospitals, ambulatory surgical centers, and others. On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include ELLA– CS, s.r.o., Boston Scientific Corporation, Hobbs Medical Inc., Becton, Dickinson & Company, W.L. Gore & Associate Inc., Medtronic Plc, MICRO-TECH (Nanjing) Co., Ltd., Q3 Medical Group, CONMED Corporation, and Cook Medical. The key players have adopted product approval as the key strategies for expansion of their product portfolio.
Key Benefits for Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non vascular stent market analysis from 2023 to 2035 to identify the prevailing non vascular stent market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the non vascular stent market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global non vascular stent market trends, key players, market segments, application areas, and market growth strategies.
Volume Market Size and Forecast
Key Market Segments
By Material Type
Metallic Stents
Non metallic Stents
By End User
Hospitals
Ambulatory Surgical Centers
Others
By Product Type
Gastrointestinal Stents
Pulmonary Stents
Urological Stents
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
ELLA – CS, s.r.o.
Becton, Dickinson, and Company
W.L. Gore & Associate Inc.
CONMED Corporation
Q3 Medical Group
Micro-tech (nanjing) Co., Ltd.
Hobbs Medical Inc.
Cook Group
Boston Scientific Corporation
Medtronic plcThe research methodology of the global market involves extensive primary and secondary research. Primary research includes about over 12 hours of interviews and discussion with a wide range of stakeholders, including upstream and downstream participants. The primary research typically is the bulk of our research efforts; however, coherently supported by extensive secondary research. Researchers have reviewed over 6,765 product literatures, industry releases, annual reports, and other such documents of key industry participants to obtain better market understanding and gain competitive intelligence. In addition, authentic industry journals, trade associations' releases,and government websites have also been reviewed for generating high-value industry insights.
Table of Contents
285 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of chronic diseases
- 3.4.1.2. Rise in preference for minimally invasive surgeries
- 3.4.1.3. Favorable Reimbursement Policies
- 3.4.2. Restraints
- 3.4.2.1. High Production Costs and Stringent Regulatory Requirements
- 3.4.3. Opportunities
- 3.4.3.1. Advancements in Material Technology
- CHAPTER 4: NON VASCULAR STENT MARKET, BY PRODUCT TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Gastrointestinal Stents
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Pulmonary Stents
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Urological Stents
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- 4.5. Others
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
- CHAPTER 5: NON VASCULAR STENT MARKET, BY MATERIAL TYPE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Metallic Stents
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Non metallic Stents
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: NON VASCULAR STENT MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Ambulatory Surgical Centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: NON VASCULAR STENT MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Product Type
- 7.2.3. Market size and forecast, by Material Type
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Market size and forecast, by Product Type
- 7.2.5.1.2. Market size and forecast, by Material Type
- 7.2.5.1.3. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Market size and forecast, by Product Type
- 7.2.5.2.2. Market size and forecast, by Material Type
- 7.2.5.2.3. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Market size and forecast, by Product Type
- 7.2.5.3.2. Market size and forecast, by Material Type
- 7.2.5.3.3. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Product Type
- 7.3.3. Market size and forecast, by Material Type
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Market size and forecast, by Product Type
- 7.3.5.1.2. Market size and forecast, by Material Type
- 7.3.5.1.3. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Market size and forecast, by Product Type
- 7.3.5.2.2. Market size and forecast, by Material Type
- 7.3.5.2.3. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Market size and forecast, by Product Type
- 7.3.5.3.2. Market size and forecast, by Material Type
- 7.3.5.3.3. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Market size and forecast, by Product Type
- 7.3.5.4.2. Market size and forecast, by Material Type
- 7.3.5.4.3. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Market size and forecast, by Product Type
- 7.3.5.5.2. Market size and forecast, by Material Type
- 7.3.5.5.3. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Market size and forecast, by Product Type
- 7.3.5.6.2. Market size and forecast, by Material Type
- 7.3.5.6.3. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Product Type
- 7.4.3. Market size and forecast, by Material Type
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Market size and forecast, by Product Type
- 7.4.5.1.2. Market size and forecast, by Material Type
- 7.4.5.1.3. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Market size and forecast, by Product Type
- 7.4.5.2.2. Market size and forecast, by Material Type
- 7.4.5.2.3. Market size and forecast, by End User
- 7.4.5.3. India
- 7.4.5.3.1. Market size and forecast, by Product Type
- 7.4.5.3.2. Market size and forecast, by Material Type
- 7.4.5.3.3. Market size and forecast, by End User
- 7.4.5.4. Australia
- 7.4.5.4.1. Market size and forecast, by Product Type
- 7.4.5.4.2. Market size and forecast, by Material Type
- 7.4.5.4.3. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Market size and forecast, by Product Type
- 7.4.5.5.2. Market size and forecast, by Material Type
- 7.4.5.5.3. Market size and forecast, by End User
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Market size and forecast, by Product Type
- 7.4.5.6.2. Market size and forecast, by Material Type
- 7.4.5.6.3. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Product Type
- 7.5.3. Market size and forecast, by Material Type
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Market size and forecast, by Product Type
- 7.5.5.1.2. Market size and forecast, by Material Type
- 7.5.5.1.3. Market size and forecast, by End User
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Market size and forecast, by Product Type
- 7.5.5.2.2. Market size and forecast, by Material Type
- 7.5.5.2.3. Market size and forecast, by End User
- 7.5.5.3. South Africa
- 7.5.5.3.1. Market size and forecast, by Product Type
- 7.5.5.3.2. Market size and forecast, by Material Type
- 7.5.5.3.3. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Market size and forecast, by Product Type
- 7.5.5.4.2. Market size and forecast, by Material Type
- 7.5.5.4.3. Market size and forecast, by End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product mapping of top 10 player
- 8.4. Competitive dashboard
- 8.5. Competitive heatmap
- 8.6. Top player positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. ELLA – CS, s.r.o.
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.2. Boston Scientific Corporation
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.3. Hobbs Medical Inc.
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.4. Becton, Dickinson, and Company
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.5. W.L. Gore & Associate Inc.
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.6. Medtronic plc
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.7. Cook Group
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.8. Micro-tech (nanjing) Co., Ltd.
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.9. Q3 Medical Group
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Key strategic moves and developments
- 9.10. CONMED Corporation
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
